NASDAQ$CERT
Certara Inc. · Q1 2026 earnings
Q1 2026 earnings · · Investor relations
Briefing
Certara reported Q1 2026 revenue of $106.9M (+0.9% YoY), a net loss of $8.8M, and diluted loss per share of $0.06.
For the quarter ended March 31, 2026, Certara posted revenue of $106.9 million, roughly flat versus $106.0 million. Income from operations was a loss of $4.3 million; net loss was $8.8 million ($0.06 per share) compared with net income of $4.7 million and $0.03 EPS in Q1 2025. Higher G&A and interest expense pressured margins; FX reduced comprehensive income.
- Revenue $106.9M (+0.9% YoY).
- Net loss $8.8M vs. net income $4.7M prior year.
- R&D $12.3M; SG&A $29.4M.
- Interest expense $4.9M on leverage from prior acquisitions.
- Biosimulation software demand stable; integration ongoing.
Headline financials
Revenue & EPS history
Certara · Revenue · Quarterly
$107M
Revenue by segment
Certara · $90.3M total across 2 segments · Q1 2023
- Services$57.3M—63.5%
- Software$33M—36.5%
Forward guidance
Certara discusses ARR, bookings, and adjusted EBITDA targets on earnings calls.
Tailwinds
- Revenue held flat in tough macro for pharma services.
Headwinds
- Swing to net loss on higher opex and interest.
- FX headwinds on comprehensive income.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2026
-4.5%
Avg return
Earnings day
-6.4%
Avg return
5 days after
-3.8%
Avg return
30 days after
33%
8 / 24 earnings
Positive
+28.1%
Q3 2022
Best reaction
-23.0%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -18.9% | -29.2% | -17.9% | |
| Q4 2025 | +3.3% | +9.9% | -12.7% | |
| Q3 2025 | -23.0% | -26.5% | -18.2% | |
| Q1 2025 | -11.0% | -6.3% | -8.5% | |
| Q3 2024 | +6.6% | +5.6% | +5.2% | |
| Q2 2024 | -12.6% | -16.1% | -23.1% | |
| Q1 2024 | -7.3% | -3.6% | -2.6% | |
| Q4 2023 | +7.8% | +9.6% | +5.3% | |
| Q3 2023 | +0.6% | +3.5% | +30.6% | |
| Q2 2023 | -10.0% | -6.5% | -19.5% | |
| Q1 2023 | -9.5% | -12.1% | -18.9% | |
| Q4 2022 | +19.4% | +18.4% | +33.1% | |
| Q3 2022 | +28.1% | +37.6% | +64.0% | |
| Q2 2022 | -15.6% | -27.2% | -32.6% | |
| Q1 2022 | -2.5% | -11.3% | -1.4% | |
| Q4 2021 | -13.5% | -21.9% | -15.2% | |
| Q4 2019 | -13.5% | -21.9% | -15.2% | |
| Q3 2021 | -5.5% | -7.4% | -33.7% | |
| Q3 2020 | -5.5% | -7.4% | -33.7% | |
| Q2 2020 | +0.6% | +0.3% | +34.9% | |
| Q2 2021 | +2.3% | -0.0% | +35.3% | |
| Q1 2020 | -0.1% | -7.9% | -10.7% | |
| Q1 2021 | -6.1% | -9.9% | -16.4% | |
| Q4 2020 | -22.2% | -23.5% | -19.1% | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro